Opinion

» genomics, science policy and opinion

Most Recent

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

image: Opinion: Pay-to-Play Publishing

Opinion: Pay-to-Play Publishing

By | September 3, 2015

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

2 Comments

image: Opinion: How Postdocs Can Participate

Opinion: How Postdocs Can Participate

By | September 18, 2014

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

6 Comments

image: Opinion: The Pitfalls of Uncertainty

Opinion: The Pitfalls of Uncertainty

By | April 14, 2014

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

2 Comments

image: Opinion: Researching the Researchers

Opinion: Researching the Researchers

By | November 25, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

9 Comments

image: Opinion: Who We Work For

Opinion: Who We Work For

By | November 5, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

1 Comment

image: Opinion: The Payoff of Big Science

Opinion: The Payoff of Big Science

By | June 3, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

3 Comments

image: Opinion: Canadian Science Under Attack

Opinion: Canadian Science Under Attack

By | April 2, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

6 Comments

image: Opinion: Life as a Target

Opinion: Life as a Target

By | March 27, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

33 Comments

image: Opinion: From Polymerase to Politics

Opinion: From Polymerase to Politics

By | February 11, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech